Longaeva Partners »

Monopar Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 56k 92.59

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics